⌘K

Login Start Free

Home/Filings/4/0001415889-25-021068

4//SEC Filing

Raykov Rosty 4

Accession 0001415889-25-021068

CIK 0001211583other

View on SEC.gov Company Profile

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 5:33 PM ET

Size

5.0 KB

Accession

0001415889-25-021068

Insider Transaction Report

Form 4

Period: 2025-08-05

FENNEC PHARMACEUTICALS INC.FENC

DirectorChief Executive Officer

Transactions

Sale
Common shares
2025-08-05$8.09/sh−10,000$80,900→ 55,878 total

Footnotes (1)

[F1]Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Documents

1 file

4
form4-08052025_090820.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001468316

Filing Metadata

Form type: 4
Filed: Aug 4, 8:00 PM ET
Accepted: Aug 5, 5:33 PM ET
Size: 5.0 KB

View on SEC.gov